Norovirus monovalent vaccine (Takeda)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNorovirus monovalent vaccine (Takeda)
Drug Alias Name诺如病毒疫苗 - 武田Norovirus dry powder vaccineNorovirus monovalent VLP vaccine
ClassificationVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCaliciviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLigocyte
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLigocyteBaylor College Of MedicineTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCaliciviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A